Cargando…
A mutated factor X activatable by thrombin corrects bleedings in vivo in a rabbit model of antibody-induced hemophilia A
Rendering coagulation factor X sensitive to thrombin was proposed as a strategy to bypass the need for factor VIII. In this study, this nonreplacement strategy was evaluated in vitro and in vivo for its ability to correct factor VIII but also factor IX, X and XI deficiencies. A novel modified factor...
Autores principales: | Abache, Toufik, Fontayne, Alexandre, Grenier, Dominique, Jacque, Emilie, Longue, Alain, Dezetter, Anne-Sophie, Souilliart, Béatrice, Chevreux, Guillaume, Bataille, Damien, Chtourou, Sami, Plantier, Jean-Luc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556615/ https://www.ncbi.nlm.nih.gov/pubmed/33054058 http://dx.doi.org/10.3324/haematol.2019.219865 |
Ejemplares similares
-
Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern
por: Fournier, Nathalie, et al.
Publicado: (2018) -
The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies
por: Monnet, Céline, et al.
Publicado: (2021) -
Thrombin activatable fibrinolysis inhibitor as a bleeding predictor
in liver transplantation: a pilot observational study
por: Nedel, Wagner Luis, et al.
Publicado: (2016) -
Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review
por: Sillen, Machteld, et al.
Publicado: (2021) -
In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype
por: Verhagen, Marieke J.A., et al.
Publicado: (2023)